Ankle‐Brachial Index and Energy Production in People Without Peripheral Artery Disease: The BLSA

Background Lower ankle‐brachial index (ABI) values within the 0.90 to 1.40 range are associated with poorer mitochondrial oxidative capacity of thigh muscles in cross‐sectional analyses. Whether ABI decline is associated with greater declines in thigh muscle oxidative capacity with aging is unknown. Method and Results We analyzed data from 228 participants (100 men) of the BLSA (Baltimore Longitudinal Study of Aging), aged 39 to 97 years, with an ABI between 0.9 and 1.40 at baseline and at follow‐up (mean follow‐up period of 2.8 years). We examined mitochondrial oxidative capacity of the left thigh muscle, by measuring the postexercise phosphocreatine recovery rate constant (kPCr) from phosphorus‐31 magnetic resonance spectroscopy. Greater kPCr indicated higher mitochondrial oxidative capacity. Although kPCr was available on the left leg only, ABI was measured in both legs. Longitudinal rates of change (Change) of left and right ABI and kPCr of the left thigh muscle were estimated using linear mixed effects models, and their association was analyzed by standardized multiple linear regressions. In multivariate analysis including sex, age, baseline kPCr, both left and right baseline ABI, and ABI change in both legs, (kPCr)Change was directly associated with ipsilateral (left) (ABI)Change (standardized [STD]‐β=0.14; P=0.0168) but not with contralateral (right) (ABI)Change (P=0.22). Adjusting for traditional cardiovascular risk factors, this association remained significant (STD‐β=0.18; P=0.0051). (kPCr)Change was steeper in White race participants (STD‐β=0.16; P=0.0122) and body mass index (STD‐β=0.13; P=0.0479). There was no significant association with current smoking status (P=0.63), fasting glucose (P=0.28), heart rate (P=0.67), mean blood pressure (P=0.78), and low‐density lipoprotein (P=0.75), high‐density lipoprotein (P=0.82), or triglycerides (P=0.15). Conclusions In people without peripheral arterial disease, greater decline in ABI over time, but not baseline ABI, was associated with faster decline in thigh mitochondrial oxidative capacity in the ipsilateral leg. Further studies are needed to examine whether early interventions that improve lower extremity muscle perfusion can improve and prevent the decline of muscle energetics.

[1]  C. Boesch,et al.  31P magnetic resonance spectroscopy in skeletal muscle: Experts' consensus recommendations , 2020, NMR in biomedicine.

[2]  L. Ferrucci,et al.  Subclinical Longitudinal Change in Ankle‐Brachial Index With Aging in a Community‐Dwelling Population Is Associated With Central Arterial Stiffening , 2019, Journal of the American Heart Association.

[3]  L. Ferrucci,et al.  The Role of Muscle Perfusion in the Age-Associated Decline of Mitochondrial Function in Healthy Individuals , 2019, Front. Physiol..

[4]  Y. le Fur,et al.  Oxygen availability and skeletal muscle oxidative capacity in patients with peripheral artery disease: implications from in vivo and in vitro assessments. , 2018, American journal of physiology. Heart and circulatory physiology.

[5]  S. Studenski,et al.  Lower Mitochondrial Energy Production of the Thigh Muscles in Patients With Low‐Normal Ankle‐Brachial Index , 2017, Journal of the American Heart Association.

[6]  S. Studenski,et al.  31P Magnetic Resonance Spectroscopy Assessment of Muscle Bioenergetics as a Predictor of Gait Speed in the Baltimore Longitudinal Study of Aging. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[7]  L. Ferrucci,et al.  Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[8]  G. Kemp,et al.  The Reproducibility of 31-Phosphorus MRS Measures of Muscle Energetics at 3 Tesla in Trained Men , 2012, PloS one.

[9]  Qun Zhao,et al.  The reproducibility of measurements of intramuscular magnesium concentrations and muscle oxidative capacity using 31P MRS , 2009, Dynamic medicine : DM.

[10]  S. Perrey,et al.  Reproducibility assessment of metabolic variables characterizing muscle energetics in Vivo: A 31P‐MRS study , 2009, Magnetic resonance in medicine.

[11]  L. Ferrucci,et al.  Associations of borderline and low normal ankle-brachial index values with functional decline at 5-year follow-up: the WALCS (Walking and Leg Circulation Study). , 2009, Journal of the American College of Cardiology.

[12]  Luigi Ferrucci,et al.  Model choice can obscure results in longitudinal studies. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[13]  I. Pipinos,et al.  The Myopathy of Peripheral Arterial Occlusive Disease: Part 1. Functional and Histomorphological Changes and Evidence for Mitochondrial Dysfunction , 2008, Vascular and endovascular surgery.

[14]  M. Schocke,et al.  Phosphocreatine Kinetics in the Calf Muscle of Patients with Bilateral Symptomatic Peripheral Arterial Disease during Exhaustive Incremental Exercise , 2007, Molecular Imaging and Biology.

[15]  B. Golomb,et al.  Exertional Leg Pain in Patients With and Without Peripheral Arterial Disease , 2005, Circulation.

[16]  J. Polak,et al.  Risk factors for declining ankle-brachial index in men and women 65 years or older: the Cardiovascular Health Study. , 2005, Archives of internal medicine.

[17]  A. Sharrett,et al.  Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. , 2005, American journal of epidemiology.

[18]  W. Hiatt,et al.  Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. , 2004, Journal of vascular surgery.

[19]  G. Zientara,et al.  Use of phosphocreatine kinetics to determine the influence of creatine on muscle mitochondrial respiration: an in vivo 31P-MRS study of oral creatine ingestion. , 2004, Journal of applied physiology.

[20]  J. Price,et al.  Changes in ankle brachial index in symptomatic and asymptomatic subjects in the general population. , 2003, Journal of Vascular Surgery.

[21]  I. Pipinos,et al.  Abnormal mitochondrial respiration in skeletal muscle in patients with peripheral arterial disease. , 2003, Journal of vascular surgery.

[22]  K. Sahlin,et al.  The role of phosphorylcreatine and creatine in the regulation of mitochondrial respiration in human skeletal muscle , 2001, The Journal of physiology.

[23]  S. Muluk,et al.  Natural history of claudication: long-term serial follow-up study of 1244 claudicants. , 2001, Journal of vascular surgery.

[24]  P. Esselman,et al.  Oxidative capacity and ageing in human muscle , 2000, The Journal of physiology.

[25]  G. Hunter,et al.  31P MRS measurement of mitochondrial function in skeletal muscle: reliability, force‐level sensitivity and relation to whole body maximal oxygen uptake , 1995, NMR in biomedicine.

[26]  S Van Huffel,et al.  Time-domain quantification of series of biomedical magnetic resonance spectroscopy signals. , 1999, Journal of magnetic resonance.

[27]  R. Langer,et al.  Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing , 1999, Vascular medicine.

[28]  J. Leigh,et al.  Relationships between in vivo and in vitro measurements of metabolism in young and old human calf muscles. , 1993, Journal of applied physiology.

[29]  I. Rossman,et al.  Normal Human Aging: The Baltimore Longitudinal Study of Aging , 1986 .

[30]  P. Matthews,et al.  Energetics of human muscle: Exercise‐induced ATP depletion , 1986, Magnetic resonance in medicine.

[31]  P. Matthews,et al.  metabolic recovery after exercise and the assessment of mitochondrial function in Vivo in human skeletal muscle by means of 31P NMR , 1984, Magnetic resonance in medicine.

[32]  J. Albers,et al.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.

[33]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.